30-05-2025
Southern Acids (M) Berhad Full Year 2025 Earnings: EPS: RM0.27 (vs RM0.10 in FY 2024)
Revenue: RM1.09b (up 19% from FY 2024).
Net income: RM36.7m (up 169% from FY 2024).
Profit margin: 3.4% (up from 1.5% in FY 2024). The increase in margin was driven by higher revenue.
EPS: RM0.27 (up from RM0.10 in FY 2024).
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Southern Acids (M) Berhad shares are down 8.3% from a week ago.
What about risks? Every company has them, and we've spotted 2 warning signs for Southern Acids (M) Berhad (of which 1 makes us a bit uncomfortable!) you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
